Simon Robson
Company: Harvard Medical School, Scientific Founder Purinomia
Job title: Professor of Medicine & Anesthesiology
Seminars:
Chair’s Closing Remarks 5:15 pm
day: Day Two
Chair’s Opening Remarks 8:50 am
day: Day Two
Targeting CD39 in Malignancy: Immunotherapy & Inhibition of Angiogenesis 1:45 pm
• Explaining the central role of CD39 in modulation of purinergic signalling viz. regulation of both extracellular nucleotide pro-inflammatory and nucleoside/adenosine immunosuppressive pathways • Demonstrating CD39 as a major rate limiting enzyme for extracellular nucleotide scavenging as well as adenosine production; given regulated catalysis of ATP/ADP to AMP and impacts of e.g. ADP on feed-forward…Read more
day: Day One